Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,512 articles

Articles by Daniel Marsh

ECB Set to Hike to 2.5%: Euro's Fate Hinges on Inflation Forecasts
Economy

ECB Set to Hike to 2.5%: Euro's Fate Hinges on Inflation Forecasts

The ECB's expected quarter-point hike to 2.50% may not move the euro. Investors await new inflation projections and Lagarde's guidance.

GLD USO
Centrus $500M Capital Raise Could Dilute Shares by 47.6%
Analysis

Centrus $500M Capital Raise Could Dilute Shares by 47.6%

Centrus Energy's $500M capital raise includes warrants that could expand share count by 47.6%. The stock fell after hours despite a headline premium.

LEU
Vale's Panda Bond Talk: Strategic Funding Option, Not Imminent Sale
Analysis

Vale's Panda Bond Talk: Strategic Funding Option, Not Imminent Sale

Vale's CFO discussed a possible panda bond, but no deal is approved. The move would diversify funding and deepen China ties, yet terms remain undisclosed.

FXI
Wizz Air Shares Slide 3.7% Amid NATS Disruption; Key Test Looms Sept 17
Markets

Wizz Air Shares Slide 3.7% Amid NATS Disruption; Key Test Looms Sept 17

Wizz Air shares dropped 3.7% as NATS disruption costs remain unclear. The airline's Capital Markets Day on Sept 17 is the bigger catalyst for investors.

TSMC's August Revenue Hits Record NT$514.8B, Easing Q3 Target
Analysis

TSMC's August Revenue Hits Record NT$514.8B, Easing Q3 Target

TSMC's August revenue hit a record NT$514.8B, up 53% YoY, easing Q3 targets. Investors now watch September sales and margin guidance.

TSM
Opus Genetics Surges 32% on Early Gene Therapy Data; Key Hurdles Ahead
Analysis

Opus Genetics Surges 32% on Early Gene Therapy Data; Key Hurdles Ahead

Opus Genetics shares soared 32% on positive early data for its experimental eye gene therapy, but the small, uncontrolled trial leaves many questions before approval.

IRD
SK hynix ADR Surges 7% but 44% Premium Raises Red Flags
Markets

SK hynix ADR Surges 7% but 44% Premium Raises Red Flags

SK hynix's US ADR jumped 7% to $198.63, but trades at a 44% premium to its Seoul-listed shares. Investors weigh AI memory growth against convergence risk.

FTFT Shares Surge 59.5% on Heavy Volume, But No Catalyst Announced
Markets

FTFT Shares Surge 59.5% on Heavy Volume, But No Catalyst Announced

FTFT shares soared 59.5% to $2.09 on heavy volume, but no company news explains the move. The rally appears speculative, with the stock still well below its split-adjusted placement price.

FTFT
ASX 200 Plunges 1.6% While ASX Ltd Holds Steady—Here's Why
Markets

ASX 200 Plunges 1.6% While ASX Ltd Holds Steady—Here's Why

The ASX 200 fell 1.6% on Thursday, but ASX Ltd shares barely moved. Higher trading volumes from volatility could offset rising costs for the exchange operator.

ASX
Pinterest Shares Slide 9% as International Overhaul Carries Short-Term Costs
Markets

Pinterest Shares Slide 9% as International Overhaul Carries Short-Term Costs

Pinterest shares dropped 9.2% after CEO Bill Ready warned of 'near-term pain' from international regulatory and go-to-market changes, despite the long-term opportunity.

PINS
Vertiv's 9.6% Slide: Valuation Reset or Warning Sign?
Analysis

Vertiv's 9.6% Slide: Valuation Reset or Warning Sign?

Vertiv's 9.6% drop on September 9 erased most of its post-acquisition rally, signaling a valuation reset rather than a business setback. The stock still trades at a premium, raising questions about sustainability.

VRT
Cloudflare's AI Security Bet: 41x Sales Test
Analysis

Cloudflare's AI Security Bet: 41x Sales Test

Cloudflare's stock surged 10.5% on its new OpenAI-powered security service, but the stock trades at 41x sales, requiring evidence of paid adoption.

NET